Amarin Corp Plc (AMRN)

[KCSVEN]

I think Omthera has a pretty easy approval for High Trigs, it would need to be worse than Lovaza in some areas to get denied.

I find it interesting they are planning to conduct a large scale cardiovascular outcomes trial for Epanova with Statins since they have not started and are now 2 years behind Vascepa. Even if they somehow have success, that means Vascepa already had success and would be over 2 years ahead in the market. Nobody would buy Epanova. If Reduce It failed then AZN would have 2-3 more years to complete their trial which would be expected to fail.

Seems like AZN is oblivious to reality in the fish oil sector, they just plod along with Epanova like it's some new drug in the sector. They have little chance of Anchor approval, they haven't even started to apply for that area so in the areas where it could ever make money they face a superior product that has several years head start in a market they may never even be approved for.